- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Clinically Significant Bacteremia in Australia
Total 65 results
-
Medical University of ViennaRecruitingClinical High Risk for Psychosis | Ultra-high Risk for Psychosis | At-risk Mental StateAustria
-
GlaxoSmithKlineTerminatedGastroparesisCanada, Australia, United States
-
Medical University of GrazEnrolling by invitationCerebral Palsy | Clinical Reasoning | General Movement AssessmentAustria
-
Australian and New Zealand Intensive Care Research...National Health and Medical Research Council, Australia; Medical Research Institute... and other collaboratorsEnrolling by invitationCritically Ill | Mechanical Ventilation | Long Term OutcomeAustralia
-
Australian and New Zealand Intensive Care Research...Melbourne Health; The Alfred; Barwon Health; Wellington Hospital; Monash Health; Austin... and other collaboratorsCompletedSepsis | Shock, Septic | Critically Ill | Vasoplegic SyndromeAustralia, New Zealand, Brazil
-
Hamilton Health Sciences CorporationCanadian Institutes of Health Research (CIHR); Canadian Critical Care Trials...CompletedCritically Ill | Deep Venous ThrombosisCanada, Australia
-
Medical University of GrazTerminatedDepression | Inflammation | Aortic Valve Stenosis | Frail Elderly Syndrome | Clinical TrialAustria
-
AmgenCompletedBlincyto Use in Routine Clinical PracticeNetherlands, France, Czechia, Sweden, Austria, Italy, Switzerland, Germany, Finland, United Kingdom, Portugal, Greece, Poland
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
Medical University InnsbruckCompletedAcute Kidney Injury | Critically Ill | Renal Replacement Therapy | Continuous Renal Replacement Therapy | Continuous Veno-Venous Hemofiltration | Replacement Fluid | Phoxilium | Biphozyl | Anticoagulation | Regional Citrate AnticoagulationAustria
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Clinically Isolated SyndromeCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Estonia, Germany, Latvia, Poland, Romania, Argentina, Finland, Israel, Greece, Czech Republic, Slovakia, Austria, Belgium, Canada, Lebanon, Morocco, Portugal, Serbia
-
AmgenCompletedAny Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical TrialCanada, Spain, United States, Germany, Austria, France, Greece, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Switzerland, United Kingdom
-
Janssen Research & Development, LLCCompletedErythroblastosis, Fetal | Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN)United States, Canada, Netherlands, Belgium, Australia, Germany, Spain, Sweden, United Kingdom
-
Infectopharm Arzneimittel GmbHINPADS GmbH; Dr. Oestreich + Partner GmbHRecruitingRespiratory Tract Infections | Sepsis | Encephalitis | Bacterial Infections | Intraabdominal Infections | Bacteremia | Skin Diseases, Bacterial | Pneumonia, Bacterial | Urinary Tract Infections | Meningitis, Bacterial | Central Nervous System Bacterial Infections | Soft Tissue Infections | Endocarditis, Bacterial | Bone Diseases, Infectious and other conditionsGermany, Austria, Greece, Italy, United Kingdom